On the SIQ conferencve call the CFO said that in H1 $1.5m of restructuring costs were incurred. I did not see this anywhere in the pack. This explains most of the remaining NPATA shortfall compared to H1 FY'19.
The CEO also said that almost all renewals so had been on similar terms and conditions apart from one small VicHealth contract. That is good news for SIQ operating margins.
SIQ Price at posting:
$6.28 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)